Genetic analysis of specific and redundant roles for p38α and p38β MAPKs during mouse development
- 18 July 2011
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 108 (31), 12764-12769
- https://doi.org/10.1073/pnas.1015013108
Abstract
P38 alpha MAPK is an important regulator of cellular responses induced by external cues, but the elucidation of physiological functions for p38 alpha has been complicated by the possible functional redundancy in vivo with the related family member p38 beta. We found that mice with combined deletion of p38 alpha and p38 beta display diverse developmental defects at midgestation, including major cardiovascular abnormalities, which are observed neither in single knockout nor in double heterozygous embryos. Expression analysis indicates specific functions of p38 alpha and p38 beta in the regulation of cardiac gene expression during development. By using knock-in animals that express p38 beta under control of the endogenous p38 alpha promoter, we also found that p38 beta cannot perform all of the functions of p38 alpha during embryogenesis. Our results identify essential roles for p38 alpha and p38 beta during development and suggest that some specific functions may be explained by differences in expression patterns.Keywords
This publication has 43 references indexed in Scilit:
- Hand2 function in second heart field progenitors is essential for cardiogenesisDevelopmental Biology, 2010
- Targeted deletion of Hand2 in cardiac neural crest-derived cells influences cardiac gene expression and outflow tract developmentDevelopmental Biology, 2010
- MicroRNA Regulatory Networks in Cardiovascular DevelopmentDevelopmental Cell, 2010
- microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heartGenes & Development, 2008
- p38α MAPK inhibits JNK activation and collaborates with IκB kinase 2 to prevent endotoxin‐induced liver failureEMBO Reports, 2008
- An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133Proceedings of the National Academy of Sciences of the United States of America, 2007
- MicroRNA-133 controls cardiac hypertrophyNature Medicine, 2007
- p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathwayNature Genetics, 2007
- A threshold of GATA4 and GATA6 expression is required for cardiovascular developmentProceedings of the National Academy of Sciences, 2006
- Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factorNature Medicine, 2002